AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2020
Jan 3, 2020
35086_dirs_2020-01-03_a878cb2a-14fd-4dea-9f48-31d7d1768582.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2019-12-31
Reporting Person: Luthringer Remy (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | Employee Stock Option (right to buy) | $7.11 | A | 95698 | Acquired | 2029-12-30 | Common Stock (95698) | Direct |
Footnotes
F1: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter.
More from Minerva Neurosciences, Inc.
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Major Shareholding Notification
2026
Feb 5